IN8BIO INC (INAB)
US45674E1091 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -30.01M | -28.52M | -14.65M | -8.56M | -5.13M | |||
| Depreciation Amortization | 1.83M | 610.00K | 630.00K | 90.00K | 100.00K | |||
| Change In Working Capital | -204.00K | -170.00K | -1.84M | 630.00K | 90.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 5.04M | 3.96M | 2.36M | 710.00K | 140.00K | |||
| OPERATING CASH FLOW | -23.34M | -24.12M | -13.51M | -7.13M | -4.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -600.00K | -3.71M | -310.00K | 0.00 | -330.00K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 690.00K | |||
| INVESTING CASH FLOW | -600.00K | -3.71M | -310.00K | 0.00 | 360.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -798.00K | -620.00K | -710.00K | 170.00K | 0.00 | |||
| Stock Issued/Repurchased | 27.84M | 9.60M | 36.36M | 25.69M | 70.00K | |||
| Other Financing Activity | N/A | 0.00 | -2.69M | -1.34M | N/A | |||
| FINANCING CASH FLOW | 27.04M | 8.99M | 32.96M | 24.52M | 70.00K | |||
| CHANGE IN CASH | 3.10M | -18.84M | 19.14M | 17.39M | -4.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -23.34M | -24.12M | -13.51M | -7.13M | -4.80M | |||
| Capital Expenditure | -600.00K | -3.71M | -310.00K | 0.00 | -330.00K | |||
| FREE CASH FLOW | -23.94M | -27.83M | -13.82M | -7.13M | -5.13M | |||
All data in USD